Concepedia
8
Publications
408
Citations
H-Index
2020
Active since
Affiliations
Leiden University Medical Center(Current)
Oncode Institute
German Cancer Research Center
Heidelberg University
National Center for Tumor Diseases
Marit J van Elsas is an author at Leiden University Medical Center.
Publications per year
2020–2025
Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy
Marit J van Elsas, Jim Middelburg, Camilla Labrie et al. · Cancer Cell · 2024 · 116 citations · Full text
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance
Mandy van Gulijk, Anneloes van Krimpen, Sjoerd Schetters et al. · Science Immunology · 2023 · 93 citations · Full text
<scp>NKG2A</scp> is a late immune checkpoint on <scp>CD8</scp> T cells and marks repeated stimulation and cell division
Linda Borst, Marjolein Sluijter, Gregor Sturm et al. · International Journal of Cancer · 2021 · 53 citations · Full text
IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors
Elham Beyranvand Nejad, Camilla Labrie, Marit J van Elsas et al. · Journal for ImmunoTherapy of Cancer · 2021 · 43 citations · Full text
Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapy
Marit J van Elsas, Camilla Labrie, Anders Etzerodt et al. · Journal for ImmunoTherapy of Cancer · 2023 · 32 citations · Full text
Rows per page
1–5 of 8